/ /

Cheryl Guttman Krader
Insights from anti-VEGF pivotal DME trials
Analyses of data collected in the RISE/RIDE and VIVID/VISTA clinical trials provide important messages about the efficacy and safety of ranibizumab (Lucentis, Genentech) and aflibercept (Eylea, Regeneron) for treatment of diabetic macular edema (DME).
Innovator in small pupil management recognized with Binkhorst Medal
At the 2006 ASCRS Film Festival, Dr. Malyugin, professor of ophthalmology and deputy director, S. Fyodorov Eye Microsurgery Institution, Moscow, received the first-place award in the instruments/devices category for his video, “Russian solution to small-pupil phaco and tamsulosin floppy-iris syndrome,” that presented the pupil expansion ring he designed for atraumatic management of the small pupil.
Ocular surface optimization key in refractive surgery management
Dry eye disease (DED) is extremely common in the adult population and important to diagnose and treat in patients undergoing corneal and cataract refractive surgery because it can affect vision, quality of life, and surgical outcomes, said Edward J. Holland, MD.
Considering laser cataract surgery in combined glaucoma procedures
Femtosecond laser-assisted cataract surgery (FLACS) has some benefits for patients and for surgeons, but it remains to be seen if it adds value when used in combined glaucoma-cataract procedures, said Leon W. Herndon Jr., MD.
Glycoprotein and peptide eyedrops promote healing of epithelial defects
Glycoprotein and peptide eyedrops are effective therapies for non-healing corneal epithelial defects that address underlying causes in the pathophysiology of these lesions.
Office preparedness for childhood emergencies
Office preparedness for childhood emergencies
Studies highlight a need for pediatrician offices to be ready to handle emergencies, available data also demonstrate that many practices, including those that have already needed to treat a critically ill child, are not adequately prepared because they lack the relevant protocols, training, and tools.

Poll

View Results